Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
#1394 Endothelin-1 and cardio-kidney events among patients with CKD, diabetes, and anemia
Finnian R. Mc Causland, B Claggett, Petr Jarolı́m, Martina M. McGrath, Emmanuel A. Burdmann, Andrew S. Levey, John J.V. McMurray, Giuseppe Remuzzi, Scott D Solomon, Marc A. Pfeffer (2025). #1394 Endothelin-1 and cardio-kidney events among patients with CKD, diabetes, and anemia. , 40(Supplement_3), DOI: https://doi.org/10.1093/ndt/gfaf116.0474.
Article16 days agoEndothelin-1 and Cardio-Kidney Events among Patients with Chronic Kidney Disease, Diabetes, and Anemia
Finnian R. Mc Causland, Brian Claggett, Petr Jarolı́m, Martina M. McGrath, Emmanuel A. Burdmann, Kai-Uwe Eckardt, Andrew S. Levey, John J.V. McMurray, Giuseppe Remuzzi, Ajay Singh, Scott D. Solomon, Robert D. Toto, Marc A. Pfeffer (2025). Endothelin-1 and Cardio-Kidney Events among Patients with Chronic Kidney Disease, Diabetes, and Anemia. , DOI: https://doi.org/10.1159/000549255.
Article16 days agoEstimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without Diabetes
Priya Vart, Muthiah Vaduganathan, Niels Jongs, Giuseppe Remuzzi, David C. Wheeler, Finnian R. Mc Causland, Glenn M. Chertow, Hiddo J.L. Heerspink (2022). Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without Diabetes. , 17(12), DOI: https://doi.org/10.2215/cjn.08900722.
Article16 days agoTreatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Finnian R. Mc Causland, Brian Claggett, Emmanuel A. Burdmann, Glenn M. Chertow, Mark E. Cooper, Kai‐Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis, Janet B. McGill, John J.V. McMurray, Patrick S. Parfrey, Hans‐Henrik Parving, Giuseppe Remuzzi, Ajay Singh, Scott D. Solomon, Robert D. Toto, Marc A. Pfeffer (2018). Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). , 73(3), DOI: https://doi.org/10.1053/j.ajkd.2018.10.006.
Article16 days agoChange in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial
Finnian R. Mc Causland, Brian Claggett, Marc A. Pfeffer, Emmanuel A. Burdmann, Kai‐Uwe Eckardt, Andrew S. Levey, John J.V. McMurray, Giuseppe Remuzzi, Ajay Singh, Scott D. Solomon, Robert D. Toto, Patrick S. Parfrey (2017). Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial. , 46(6), DOI: https://doi.org/10.1159/000485326.
Article16 days ago